Korsana Biosciences

korsana.com

Biotechnology company developing brain-penetrant therapeutics for neurodegenerative diseases using its proprietary THETA shuttle platform.

Website LinkedIn Careers

Employees11-50

Funding$175M

7 active roles

OtherSeries A$50M-$200M

About

Korsana Biosciences is a biotechnology company developing brain-penetrant therapeutics for neurodegenerative diseases, specifically targeting Alzheimer's disease. They utilize their proprietary THETA platform, developed with Paragon Therapeutics, to deliver monoclonal antibodies across the blood-brain barrier. The company focuses on high-impact clinical milestones to reduce the burden of CNS diseases.

Active Roles

Associate Director / Director, CMC Project Management

Waltham, MA/Other/6d ago

Scientist/Sr. Scientist, Oligo Biology - In Vitro (REMOTE)Remote

Remote (United States)/Other/13d ago

Scientist/Sr. Scientist, Oligo Chemistry (REMOTE)Remote

Remote (United States)/Other/13d ago

Manager/Sr. Manager, Accounting and External Reporting

Waltham, MA/Finance/13d ago

Executive Assistant

Waltham, MA/Other/13d ago

Director, Competitive Intelligence – Corporate Strategy

Hybrid/Other/13d ago

Associate Director / Director, IT

Waltham, MA/Other/13d ago

Key Investors

Wellington Management, TCG Crossover, J.P. Morgan Life Sciences Private Capital, Janus Henderson Investors, Sanofi Ventures, Foresite Capital, Fairmount, Venrock Healthcare Capital Partners